Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia Guidelines
| Authors: | Staber, P. B.; Herling, M.; Bellido, M.; Jacobsen, E. D.; Davids, M. S.; Kadia, T. M.; Shustov, A.; Tournilhac, O.; Bachy, E.; Zaja, F.; Porkka, K.; Hoermann, G.; Simonitsch-Klupp, I.; Haferlach, C.; Kubicek, S.; Mayerhoefer, M. E.; Hopfinger, G.; Jaeger, U.; Dearden, C. |
| Title: | Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia |
| Abstract: | T-cell prolymphocytic leukemia (T-PLL) is a rare, mature T-cell neoplasm with a heterogeneous clinical course. With the advent of novel treatment options that will potentially change the management of patients with T-PLL, it has become necessary to produce consensus guidelines for the design and conduct of clinical trials. The T-PLL International Study group (TPLL-ISG) set out to define standardized criteria for diagnosis, treatment indication, and evaluation of response. These criteria will facilitate comparison of results from clinical trials in T-PLL, and will thus support clinical decision making, as well as the approval of new therapeutics by healthcare authorities. © 2019 American Society of Hematology. All rights reserved. |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | 14 |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-10-03 |
| Start Page: | 1132 |
| End Page: | 1143 |
| Language: | English |
| DOI: | 10.1182/blood.2019000402 |
| PUBMED: | 31292114 |
| PROVIDER: | scopus |
| PMCID: | PMC7042666 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 1 November 2019 -- Source: Scopus |
